Apart from its anti-metastatic effect in breast cancer [16,17], recent studies showed that LIF/LIFR signalling could negatively regulate metastasis of pancreatic cancer (PC) and hepatocellular carcinoma (HCC) cells both in vitro and in vivo [23,24]. Here, LIFR is linked to breast cancer.